Cancer Drug Prices to Fall by Up to 93% From Nov 9
The Centre has capped profit margins on 543 cancer drug brands, and some prices will drop by as much as 93 per cent. The new limits start on 9 November. The move is part of a wider push to look at drug price caps, hospital markups and what patients pay for cancer treatment.
Context
Context: India's government sets ceiling prices for many medicines, and high treatment costs often push families into debt. Cancer care is a growing concern, so a cap on margins can change what patients pay at the pharmacy.
Burning Potato score: 78%